The global Full Service CRO market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the "Full Service CRO Industry Forecast" looks at past sales and reviews total world Full Service CRO sales in 2022, providing a comprehensive analysis by region and market sector of projected Full Service CRO sales for 2023 through 2029.

This Insight Report provides a comprehensive analysis of the global Full Service CRO landscape and highlights key trends related to product segmentation, company formation, revenue, market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Full Service CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Full Service CRO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Full Service CRO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

United States market for Full Service CRO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Full Service CRO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Full Service CRO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Full Service CRO players cover:

• Labcorp
• IQVIA
• Parexel
• Syneos Health
• PRA Health Sciences

This report presents a comprehensive overview, market shares, and growth opportunities of Full Service CRO market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Phase I Trial
• Phase II Trial
• Phase III Trial
• Phase IV Trial

Segmentation by Application:

• Pharmaceutical
• Bio-pharm
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and its market penetration.

• Labcorp
• IQVIA
• Parexel
• Syneos Health
• PRA Health Sciences
• PPD
• ICON
• MedPace
• Wuxi AppTec